What is INNO.CN's gross margin?

InnoCan Pharma (INNO.CN) has a gross margin of 91% and a net margin of -1%.

What is INNO.CN's P/E ratio?

Track InnoCan Pharma (INNO.CN) P/E ratio, ROE, and valuation metrics over time.

Where can I see INNO.CN's full financials?

See InnoCan Pharma (INNO.CN) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

InnoCan Pharma (INNO.CN) Financials — Revenue, Earnings, Cash Flow

C$2.20 ($1.54)

-0.15 (-6.38%)

CNQ · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 53 · C$9.9M mcap · 4M float · 0.039% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers

📊 Key Metrics

TTM

C$23M

Revenue

-18.6% YoY

C$-1M

Net Income

+40.2% YoY

C$-2M

Free Cash Flow

-228.8% YoY

90.8%

Gross Margin

-9.7%

Op. Margin

-0.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-20.9%

ROA-8.8%

ROIC-13549.9%

Valuation

P/E-7.4

P/B1.4

EV/EBITDA0.0

Leverage

Debt/Equity0.35

Current Ratio4.99

Interest Cov.-43.4x

Quality Scores

Piotroski F3/9

Altman Z—

Beneish M-1.76